Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

769893

	registered interest
	date	12/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	AAT Deficiency: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he has taken to implement the recommendations made by the Prescribed Specialised Services Advisory Group on 10 March 2017 on Alpha 1 Anti-Trypsyn services.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	107601
	answer	answer is ministerial correction date of answer 19/10/2017 answer text <p>The Prescribed Specialised Services Advisory Group recommended that this become a directly commissioned service by NHS England. Ministers have accepted this recommendation but agreed to NHS England’s request for more time to prepare for a transfer. As such, NHS England has agreed to work towards becoming the responsible commissioner from April 2018 to give NHS England time to identify patients and build an appropriate service specification.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/10/2017 16:29:43 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1045633

	registered interest
	date	21/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electromagnetic Fields: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made on the health-related effects of electromagnetic fields.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	210707
	answer	answer is ministerial correction date of answer 29/01/2019 answer text <p>The independent Advisory Group on Non-ionising Radiation (AGNIR) published a comprehensive evidence review in 2012. The group’s overall conclusion was that although a substantial amount of research has been conducted in this area, there is no convincing evidence that electromagnetic field exposures below guideline levels cause health effects in either adults or children. The guideline levels are those of the International Commission on Non-Ionizing Radiation Protection, as used in the United Kingdom. Public Health England has committed to keeping emerging evidence under review and preparing another comprehensive review when sufficient new evidence has accumulated. The AGNIR report can be viewed at the following link:</p><p><a href="https://www.gov.uk/government/publications/radiofrequency-electromagnetic-fields-health-effects" target="_blank">https://www.gov.uk/government/publications/radiofrequency-electromagnetic-fields-health-effects</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/01/2019 17:29:39 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1003743

	registered interest
	date	09/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the (a) knowledge and (b) awareness among GPs of the benefits of medicinal cannabis.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	189815
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>The Government has rescheduled cannabis-based products for medicinal use from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001. Doctors on the specialist register of the General Medical Council may now prescribe these products where there might be potential benefit to individual patients. General practitioners will not be able to prescribe but the Government has commissioned the National Institute for Health and Care Excellence to produce guidance for all clinicians by October 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 11:38:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1037901

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of (a) prescriptions of and (b) patients who will use medical cannabis in the next 12 months.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	206443
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p><p> </p><p>The Department has made no estimate of future demand for medical cannabis over the next 12 months.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206441 206442 question first answered 16/01/2019 15:13:41 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

943843

	registered interest
	date	18/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he is having with NHS England to ensure that consultants are aware of the licensing process for access to medical cannabis.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	165715
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>The Department is working with NHS England and equivalents in the devolved administrations to ensure that cannabis-based medicinal products are sourced and supplied where a licence is granted. In the longer-term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p><p>Guidance on the licensing process for access to cannabis and cannabis-based medicinal products is available on the Home Office Gov.uk website.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 15:04:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1082731

	registered interest
	date	06/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electromagnetic Fields: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 January 2019 to Question 210707 on electromagnetic fields: health hazards, whether the independent Advisory Group on Non-ionising Radiation plans to make an assessment of the effect on health of (a) developments and advances in the use and coverage of wireless signals across the UK since 2012 and (b) the roll out 5G networks.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	229277
	answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The independent Advisory Group on Non-ionising Radiation (AGNIR) came to an end in 2017. Further information can be seen at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/groups/advisory-group-on-non-ionising-radiation-agnir" target="_blank">https://www.gov.uk/government/groups/advisory-group-on-non-ionising-radiation-agnir</a></p><p> </p><p>Public Health England (PHE) continues to monitor the health-related evidence in respect of electromagnetic fields, including the radio waves from developing wireless communication systems such as 5G. PHE remains committed to delivering expert review reports on non-ionising radiation topics, as and when sufficient new evidence has accumulated.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 13:24:18 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

933959

	registered interest
	date	02/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Analgesics
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 February 2017 to Question 60736 on Analgesics, what the cost to the NHS was of purchasing opioid painkillers in 2016.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	159704
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>The net ingredient cost to the National Health Service of opioid painkillers of items prescribed in the United Kingdom and dispensed in England for 2016 is provided in the following table.</p><table><tbody><tr><td><p>Year</p></td><td><p>Primary Care</p></td><td><p>Secondary Care</p></td><td><p>Total</p></td></tr><tr><td><p>2016</p></td><td><p>292,085,464</p></td><td><p>33,551,583</p></td><td><p>325,637,046</p></td></tr></tbody></table><p> </p><p>Source: Prescription Cost Analysis; IQVIA 2018: Hospital Pharmacy Audit Index</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/07/2018 15:50:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1086722

	registered interest
	date	11/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	National Drug Treatment Monitoring System
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much money from the public purse was allocated to the national drug treatment monitoring system by the Government in each year from 2010 to 2018.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	230911
	answer	answer is ministerial correction date of answer 19/03/2019 answer text <p>Data on how much money from the public purse was allocated to the National Drug Treatment Monitoring Service by the United Kingdom Government for each year from 2010 to 2018 is not held in the format requested.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/03/2019 16:25:39 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1019445

	registered interest
	date	03/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Nabiximols
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people in England have been prescribed Sativex in each year since 2010
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	198333
	answer	answer is ministerial correction date of answer 11/12/2018 answer text <p>NHS Digital reports that it does not hold information on the number of people in England who were prescribed Sativex in the years specified.</p><p> </p><p>NHS Digital does, however, hold data about prescription items dispensed by doctors and community pharmacies in England, which is detailed in the following table.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Cannabis (Sativex)</p></td></tr><tr><td><p>2010</p></td><td><p>2,502</p></td></tr><tr><td><p>2011</p></td><td><p>2,964</p></td></tr><tr><td><p>2012</p></td><td><p>2,813</p></td></tr><tr><td><p>2013</p></td><td><p>2,832</p></td></tr><tr><td><p>2014</p></td><td><p>2,703</p></td></tr><tr><td><p>2015</p></td><td><p>2,448</p></td></tr><tr><td><p>2016</p></td><td><p>2,249</p></td></tr><tr><td><p>2017</p></td><td><p>2,204</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis, NHS Digital</p><p> </p><p>Notes:</p><ol><li>Information is provided for Cannabis (Sativex) as listed in the British National Formulary in Section 10.2.2 – Skeletal muscle relaxants, using the classification system prior to edition 70.</li><li>NHS Digital does not hold data on drugs dispensed in hospitals, including mental health trusts, or private prescriptions.</li><li>NHS Digital does not hold data about prescriptions written but not dispensed.</li></ol> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2018 16:52:23 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi

1037890

	registered interest
	date	08/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many NHS prescriptions have been issued for patients to use medical cannabis since 1 November 2018.
	tabling member constituency	Gower
	tabling member printed	Tonia Antoniazzi
	uin	206441
	answer	answer is ministerial correction date of answer 16/01/2019 answer text <p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.</p><p> </p><p>The Department has made no estimate of future demand for medical cannabis over the next 12 months.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 206442 206443 question first answered 16/01/2019 15:13:41 answering member 4067 label Biography information for Steve Brine
	tabling member	4623 label Biography information for Tonia Antoniazzi